Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 26,300
-100 (-0.38%)
At close: Jul 25, 2025, 3:30 PM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 183.28 billion as of July 25, 2025. Its market cap has increased by 39.89% in one year.
Market Cap
183.28B
Enterprise Value
-42.57B
Revenue
69.65B
Ranking
n/a
PE Ratio
11.72
Stock Price
26,300.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 183.28B, an increase of 939.89%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 183.28B | 69.68% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | 111.13B | 0.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.87T |
| Celltrion | 39.24T |
| ALTEOGEN | 24.69T |
| Yuhan | 9,152.41B |
| SK Biopharmaceuticals | 8,034.94B |
| Peptron | 6,663.04B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 5,797.42B |